Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
This is a Phase I multicenter, open label, nonrandomized study of enadenotucirev administered in combination with nivolumab in subjects with metastatic or advanced epithelial tumors (with focus on CRC, SCCHN, escalation phase), not responding to standard therapy.
创建时间：
2016-01-15
相关数据集
暂无相关数据集
